mySugr now allows control of the Accu-Chek Insight insulin pump directly via smartphone, starting in Austria, bringing more discretion and simplicity to the life of people with diabetes.

Roche and Lilly will integrate data from Lilly’s connected insulin pen solution into the mySugr app in several countries. Both companies are dedicated to driving new possibilities to ease the complexity of daily decision making for people with diabetes on insulin pen therapy and their healthcare professionals.

The connection of the Novo Nordisk® smart insulin pens with the mySugr Logbook is now available on iOS in the first country Sweden, with more markets to follow. Bringing data together and setting it into context provides patients and healthcare professionals with a broader picture of the individual diabetes therapy and aims to support its optimization.

The Accu-Chek Insight insulin pump from Roche will be the first pump with a pre-filled cartridge that can be operated in loop mode. As part of DBLG1 System from Diabeloop, the Accu-Chek Insight insulin pump will enable people with diabetes to better manage their diabetes and improve their time in range.

The partnership will create new opportunities to lower the burden for people with diabetes in daily therapy management and to improve therapy outcomes. By partnering with Diabeloop, Roche steps into the field of automated insulin delivery (AID) representing a milestone in Roche’s strategy of integrated Personalised Diabetes Management (iPDM).